| HOME >> BIOLOGY >> TECHNOLOGY |
Three Months Ended June 30,Six Months Ended June 30,2012201120122011Net Loss (Per GAAP)
$
(744,069)$(2,503,505)$(1,837,721)$(5,851,067)Add back:Income Taxes
----Financing expense associated with beneficial conversion of notepayable issued in conjunction with acquisition
86,33560,599166,688133,517Financing expense associated with beneficial conversion of Lineof Credit with Related Party
150,880-162,303-Financing expense associated with beneficial conversion ofSenior Secured Promissory Note
230,744-444,698-Other interest expense, net
158,59426,471315,15134,809Depreciation Expense
121,103115,682231,491231,862Amortization Expense
333,977333,977667,954667,954Employee Share Based Compensation
478,442429,096878,491809,469Other Share Based Compensation
106,773114,648207,709222,208Earnings/(Loss) Before Interest, Taxes, Depreciation, Amortizationand Share-Based Compensation
$
922,779$(1,423,032)$ 1,236,764$(3,751,248)
| SOURCE MiMedx, Inc. Copyright©2012 PR Newswire. All rights reserved |